SOX11 is a transcription factor that plays crucial roles in development and disease pathogenesis. In cancer biology, SOX11 expression serves as a key determinant of tumor aggressiveness and clinical behavior. In mantle cell lymphoma (MCL), SOX11 expression defines aggressive phenotypes associated with chr2 alterations and somatic mutations, while SOX11-negative MCL typically presents with indolent clinical behavior 1. SOX11 expression correlates with poor prognosis in various malignancies, including group 3 medulloblastomas where it functions as a transcriptional determinant in transitional cerebellar progenitor populations 2. In pancreatic ductal adenocarcinoma, SOX11 acts as a key transcription factor in ECM-remodeling cancer-associated fibroblasts that promote tumor progression 3. Beyond oncology, SOX11 mutations cause Coffin-Siris syndrome, a multi-system intellectual disability disorder characterized by developmental delays and organ system anomalies, as SOX11 is part of the BAF chr2 remodeling complex 4. The protein's role in neurodevelopmental differences and organ-related complications makes it particularly important for understanding both developmental biology and cancer pathogenesis 4.